Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease

PHASE3RecruitingINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

November 20, 2024

Primary Completion Date

October 31, 2029

Study Completion Date

December 31, 2030

Conditions
Graft-versus-host Disease
Interventions
DRUG

Rovadicitinib

Rovadicitinib is an inhibitor of Janus associated kinases (JAK) family and Rho associated kinases (ROCK). It can inhibit the sustained abnormal activation of the Janus kinase (JAK) signal transducer and activator of transcription (JAK-STAT) pathway and also inhibit Rho associated kinase 2 (ROCK2). The JAK 1-JAK 2 signaling pathway is a key step in causing inflammation and tissue damage in acute and chronic graft-versus-host disease.

DRUG

Imatinib

Imatinib tyrosine kinase inhibitor is a small molecule protein kinase inhibitor that has the ability to block one or more protein kinases. Clinically used for the treatment of chronic myeloid leukemia and malignant gastrointestinal stromal tumors.

DRUG

Methotrexate

Methotrexate is an organic compound, mainly used as an anti folate anti-tumor drug. It inhibits the synthesis of tumor cells by inhibiting dihydrofolate reductase, thereby inhibiting the growth and reproduction of tumor cells.

DRUG

Mycophenolate mofetil

Metoprolol ester is an organic compound mainly used as an immunosuppressant

DRUG

Rituximab

Rituximab activates antibody dependent cell-mediated phagocytosis and complement dependent cytotoxicity by binding to cluster of differentiation 20 (CD20) antigen, clearing malignant B cells expressing CD20 and achieving therapeutic goals.

Trial Locations (41)

100034

NOT_YET_RECRUITING

Peking University First Hospital, Beijing

100044

NOT_YET_RECRUITING

Peking University People's Hospital, Beijing

110001

NOT_YET_RECRUITING

The First Hospital of China Medical University, Shenyang

130031

NOT_YET_RECRUITING

First Hospital of Jilin University, Changchun

200001

NOT_YET_RECRUITING

Shanghai Jiao Tong University School of Medicine,Renji Hospital, Shanghai

200025

NOT_YET_RECRUITING

Ruijin Hospital, Shanghai Jiaotong University School Of Medicine, Shanghai

210009

NOT_YET_RECRUITING

Zhongda Hospital Southeast University, Nanjing

210029

NOT_YET_RECRUITING

Jiangsu Province Hospital, Nanjing

223200

NOT_YET_RECRUITING

Huai'an Second People's Hospital, Huai'an

230001

NOT_YET_RECRUITING

The First Affiliated Hospital of USTC Anhui Provincial Hospital, Hefei

250012

NOT_YET_RECRUITING

Qilu Hospital of Shandong University, Jinan

271000

NOT_YET_RECRUITING

Tai'an City Central Hospital, Tai’an

300052

NOT_YET_RECRUITING

Chinese Academy of Medical Sciences Hematology Hospital, Tianjin

310003

RECRUITING

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

315040

NOT_YET_RECRUITING

The Affiliated People's Hospital of Ningbo University, Ningbo

315211

NOT_YET_RECRUITING

The First Affiliated Hospital of Ningbo University, Ningbo

325005

NOT_YET_RECRUITING

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

330006

NOT_YET_RECRUITING

The First Affiliated Hospital of Nanchang University, Nanchang

350001

NOT_YET_RECRUITING

Fujian Medical University Union Hospital, Fuzhou

361003

NOT_YET_RECRUITING

The First Affiliated Hospital of Xiamen University, Xiamen

400038

NOT_YET_RECRUITING

The Southwest Hospital of AMU, Chongqing

430022

NOT_YET_RECRUITING

Wuhan Union Hospital of China, Wuhan

430030

NOT_YET_RECRUITING

Tongji Hospital Tongji Medical College of HUST, Wuhan

430071

NOT_YET_RECRUITING

Zhongnan Hospital of Wuhan University, Wuhan

450000

RECRUITING

Henan Cancer Hospital, Zhenzhou

450003

NOT_YET_RECRUITING

Henan Provincial People's Hospital, Zhengzhou

450099

NOT_YET_RECRUITING

The Third People's Hospital of Zhengzhou, Zhengzhou

510180

NOT_YET_RECRUITING

Guangzhou First People's Hospital The First People's Hospital Affiliated to Guangzhou Medical University, Guangzhou

510515

NOT_YET_RECRUITING

Nanfang Hospital, Guangzhou

530021

NOT_YET_RECRUITING

The First Affiliated Hospital of Guangxi Medical University, Nanning

550001

NOT_YET_RECRUITING

The Affiliated Hospital of Guizhou Medical University, Guiyang

610072

NOT_YET_RECRUITING

Sichuan Provincial People's Hospital, Chengdu

650032

NOT_YET_RECRUITING

The First People's Hospital of Yunnan Province, Kunming

710061

NOT_YET_RECRUITING

The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an

710068

NOT_YET_RECRUITING

Shanxi Provincial People's Hospital, Xi’an

730000

NOT_YET_RECRUITING

The First Hospital of Lanzhou University, Lanzhou

730050

NOT_YET_RECRUITING

The 904 Hospital of the Joint Service Support Force of the People's Liberation Army of China, Lanzhou

830054

NOT_YET_RECRUITING

The First Hospital of Xinjiang Medical University, Ürümqi

050000

NOT_YET_RECRUITING

The Second Hospital of Hebei Medical Hospital, Shijiazhuang

Hunan

NOT_YET_RECRUITING

The Second Xiangya Hospital of Central South University, Changsha

030032

NOT_YET_RECRUITING

Shanxi Bethune Hospital, Taiyuan

All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY